Contents

Current Pharmaceutical Design, Volume 20 - Number 39

Editorial

Editorial (Thematic Issue: Modifying Cardiovascular Risk Factors: Newer Advances in Cardiovascular Metabolism and Diagnostic Technologies)

, 20(39): 6073 - 6077

Aurelio Leone


DOI: 10.2174/1381612820666140417114511




Modification of Lifestyle Factors are Needed to Improve the Metabolic Health of Patients with Cardiovascular Disease Risk

, 20(39): 6078 - 6088

Linda Landini


DOI: 10.2174/1381612820666140417094458




New Insight into Urate-Related Mechanism of Cardiovascular Damage

, 20(39): 6089 - 6095

Davide Grassi, Giovambattista Desideri and Claudio Ferri


DOI: 10.2174/1381612820666140417095730




Hypertension and Atrial Fibrillation: Any Change with the New Anticoagulants

, 20(39): 6096 - 6105

Lorenzo Ghiadoni, Stefano Taddei and Agostino Virdis


DOI: 10.2174/1381612820666140417100251




Treating Arterial Stiffness in Young and Elderly Patients with the Metabolic Syndrome

, 20(39): 6106 - 6113

Konstantinos Tziomalos, Vasilios G. Athyros and Asterios Karagiannis


DOI: 10.2174/1381612820666140417101523




Psoriasis and Vascular Risk : An Update

, 20(39): 6114 - 6125

Niki Katsiki, Panagiotis Anagnostis, Vasilios G. Athyros, Asterios Karagiannis and Dimitri P. Mikhailidis


DOI: 10.2174/1381612820666140417105323




Imaging of Organ Metabolism in Obesity and Diabetes: Treatment Perspectives

, 20(39): 6126 - 6149

Hannukainen J.C., Guzzardi M.A., Virtanen K.A., Sanguinetti E., Nuutila P. and Iozzo P.


DOI: 10.2174/1381612820666140417110132




Cardiological Ultrasound Imaging

, 20(39): 6150 - 6161

Johan M. Thijssen and Chris L. de Korte


DOI: 10.2174/1381612820666140417113304




Hyperpolarized Metabolic MR in the Study of Cardiac Function and Disease

, 20(39): 6162 - 6170

M.H. Lauritzen, L.V. Sogaard, P.L. Madsen and J.H. Ardenkjaer-Larsen


DOI: 10.2174/1381612820666140417113720




Models and Methods in Cardiac Imaging for Metabolism Studies

, 20(39): 6171 - 6181

Santarelli M.F., Martini N., Positano P. and Landini L.


DOI: 10.2174/1381612820666140417114122




SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target

, 20(39): 6182 - 6190

Jianguo Feng and Liling Tang


DOI: 10.2174/1381612820666140619123255




The Case for Using Higher Doses of First Line Anti-Tuberculosis Drugs to Optimize Efficacy

, 20(39): 6191 - 6206

Sylvain Goutelle, Laurent Bourguignon, Pascal Maire, Roger W. Jelliffe and Michael N. Neely


DOI: 10.2174/1381612820666140901215544




Mycobacterium w Immunotherapy for Treating Pulmonary Tuberculosis - a Systematic Review

, 20(39): 6207 - 6214

Shaheen Pandie, Mark E. Engel, Zita S. Kerbelker and Bongani M. Mayosi


DOI: 10.2174/1381612820666140905150215




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science